Researcher at Universidad de Santiago developed a new immunotherapy for cancer
The new therapy involves the development of a vaccine that provides the immune system with the tools needed to “attack” cancer cells, improving the antitumour response of the body. The therapy was announced to foreign media correspondents accredited in Chile.
The study is funded through a Fondecyt Project and it is at preclinical stage. It considers a significant decrease of more than 70% in the overall cost of therapies for this disease.
